July 29, 2021 09:11 AM EDT
Coronavirus

Covid-19 roundup: Eli Lil­ly's RA drug gets so­lo OK from FDA; Emer­gent gets green­light to re­sume man­u­fac­tur­ing at Bayview site

Josh Sullivan

The FDA late Wednes­day ex­tend­ed the EUA for Eli Lil­ly’s rheuma­toid arthri­tis drug Olu­mi­ant (baric­i­tinib) to be used as a so­lo …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times